InnoSIGN
The InnoSIGN team is committed to transform cancer care by enabling personalized targeted therapy options through OncoSIGNal pathway activity profiling. Our team has a wealth of experience in bringing innovative diagnostic solutions to the market.
Latest Content
Product News
Scipher Medicine and InnoSIGN Announce Partnership To Advance Precision Medicine in Immunology
Scipher and InnoSIGN partner to decode immune diseases using RNAseq and AI-based signaling pathway analysis.
Product News
InnoSIGN Launches New Suite Products for Pharmaceutical Research and Clinical Studies
Analysis of aberrant pathway signaling provides the greatest insight into targeted therapies.
Advertisement
